AKT1 and Miyoshi myopathy: Therefore, to test if this mechanism could be responsible of β-catenin and AKT degradation upon CK1α inhibition also in MM cells, we treated INA-6 cells with D4476 and the pan-caspase inhibitor Z-VAD-FMK.